000 01521 a2200433 4500
005 20250516040453.0
264 0 _c20111212
008 201112s 0 0 eng d
022 _a1878-5832
024 7 _a10.1016/j.drudis.2011.05.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVanderwall, Dana E
245 0 0 _aMolecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
_h[electronic resource]
260 _bDrug discovery today
_cAug 2011
300 _a646-53 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aDatabases, Factual
650 0 4 _aDrug Design
650 0 4 _aDrug Discovery
_xmethods
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aDrug Industry
_xmethods
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aHumans
650 0 4 _aPharmaceutical Preparations
_xchemistry
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aToxicology
_xmethods
700 1 _aYuen, Nancy
700 1 _aAl-Ansari, Mohammad
700 1 _aBailey, James
700 1 _aFram, David
700 1 _aGreen, Darren V S
700 1 _aPickett, Stephen
700 1 _aVitulli, Giovanni
700 1 _aLuengo, Juan I
700 1 _aAlmenoff, June S
773 0 _tDrug discovery today
_gvol. 16
_gno. 15-16
_gp. 646-53
856 4 0 _uhttps://doi.org/10.1016/j.drudis.2011.05.001
_zAvailable from publisher's website
999 _c20863380
_d20863380